Journal
PHARMACEUTICALS
Volume 15, Issue 8, Pages -Publisher
MDPI
DOI: 10.3390/ph15080978
Keywords
wound healing; copper Schiff base; hydrogel; solid lipid nanoparticles; 8-hydroxy quinoline
Categories
Funding
- Deanship of Scientific Research at King Khalid University, Abha, Saudi Arabia [RGP.1/280/43]
Ask authors/readers for more resources
Wound dressings created using nanotechnology, specifically a hydrogel loaded with Cu (II) Schiff base 8-hydroxy quinoline complex solid lipid nanoparticles (CuSQ SLN), have shown promising potential for accelerating wound healing. In this study, CuSQ SLN hydrogel demonstrated good stability, no skin irritation, and no cytotoxicity on human skin cells. In vivo experiments on rats revealed that CuSQ hydrogel significantly enhanced wound healing through the regulation of various cytokines and growth factors, resulting in improved collagen synthesis, fibroblast proliferation, angiogenesis, and reduced inflammation.
Wound dressings created using nanotechnology are known as suitable substrates to speed up the healing of both acute and chronic wounds. Therapeutic substances can be delivered using these materials. In this study, a hydrogel loaded with Cu (II) Schiff base 8-hydroxy quinoline complex (CuSQ) solid lipid nanoparticles (SLN) was formulated to investigate its wound healing potential in an excision wound healing model in rats. The CuSQ SLN were spherical shaped with sizes ranging from 111 to 202 nm and a polydispersity index (PDI) ranging from 0.43 to 0.76, encapsulation efficiency (EE) % between 85 and 88, and zeta potential (ZP) of -11.8 to -40 mV. The formulated hydrogel showed good homogeneity, good stability, and a pH of 6.4 which indicates no skin irritation and had no cytotoxicity on the human skin fibroblast (HSF) cell line. In the in vivo study, animals were placed in five groups: control, standard, plain hydrogel, low dose, and high dose of CuSQ hydrogel. Both doses of CuSQ showed significantly faster healing rates compared to standard and control rats. In addition, the histopathology study showed more collagen, improved angiogenesis, and intact re-epithelization with less inflammation. A significant increase in transforming growth factor-beta1 (TGF-beta 1) level and increased immune expression of vascular endothelial growth factor (VEGF) by CuSQ treatment validates its role in collagen synthesis, proliferation of fibroblasts and enhancement of angiogenesis. Matrix metalloproteinase-9 (MMP-9) was found to be significantly reduced after CuSQ treatment. Immunohistochemistry of tumor necrosis factor alpha (TNF-alpha) revealed a marked decrease in inflammation. Thus, we concluded that CuSQ would be a beneficial drug for cutaneous wound healing since it effectively accelerated wound healing through regulation of various cytokines and growth factors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available